Market Cap 1.04B
Revenue (ttm) 160.18M
Net Income (ttm) -69.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -43.33%
Debt to Equity Ratio 1.89
Volume 2,876,400
Avg Vol 5,237,680
Day's Range N/A - N/A
Shares Out 262.64M
Stochastic %K 67%
Beta 0.88
Analysts Strong Sell
Price Target $7.40

Company Profile

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control the serum phospho...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 617 871 2098
Fax: 617 871 2099
Address:
245 First Street, Suite 1400, Cambridge, United States
Magic_Money
Magic_Money Jul. 16 at 10:29 AM
$AKBA Sales cure all concerns. Q2 will highlight SDO uptake. Adoption should be stellar in these early stages. Q3 adds LDO participation. We should see a break of $5 after Q2 ER and head toward $7.5, or more, for Q3 ER.
0 · Reply
King_JK
King_JK Jul. 16 at 10:00 AM
$AKBA 7.5$
0 · Reply
Nikkosi
Nikkosi Jul. 16 at 9:42 AM
$AKBA I’m expecting a PR around July 30th with the earnings report date. Until then, don’t count on any other announcements. Shorts will likely try to drag this down to key support levels in the meantime. This might be a good time to grab some before the earnings run-up.
0 · Reply
BioLove
BioLove Jul. 16 at 7:38 AM
0 · Reply
Bulltrader988
Bulltrader988 Jul. 16 at 5:58 AM
$AKBA waiting for news and earnings 🦄👃👀
0 · Reply
Djinn88
Djinn88 Jul. 16 at 5:53 AM
$AKBA Blocked Pithy. Jesus does this guy have a life? Literally posting every 5 minutes.
1 · Reply
Mr_Pithy
Mr_Pithy Jul. 16 at 5:22 AM
$AKBA AKEBIA EARNINGS “BLOWOUT” OR “BEAT” IN 2ND QUARTER 2025 - Earnings “blowout” occurs when a company significantly beats earnings expectations. Analysts publish their earnings expectations before earnings are announced. Earnings expectations from all of the analysts who are following a company, are added together and averaged out, creating a consensus earnings estimate. If the earnings number is much higher (~$100M) than the consensus estimate, then this constitutes an earnings blowout. A blowout is not the same as when a company “beats” analysts expectations, as Akebia did in the 1st quarter of 2025. Revenues exceeded analysts estimates by 29%. (Simply Wall St., May 10, 2025). Expect an earnings blowout on August 7, 2025 (unconfirmed), Akebia’s business and financial highlights conference call. (See @Mr_Pithy 07-15-25 at 7:08 p.m.) Good luck 🍀 to all of us.
1 · Reply
StockHawkZero
StockHawkZero Jul. 16 at 5:17 AM
$AKBA I love how the short borrow rates have doubled in the past couple of months. It must be so painful not to be able to cover. Poor shorties. Said figuratively and soon - very much realistically.
0 · Reply
PharmaExpert
PharmaExpert Jul. 16 at 3:08 AM
$AKBA Blowout (minimum 100m) Q2 Earning report coming in 4 weeks! 🔥 https://www.nasdaq.com/market-activity/stocks/akba/earnings
0 · Reply
Lorenzo89
Lorenzo89 Jul. 15 at 11:18 PM
$AKBA folks why this thang ain’t moving ??!🤦🏾‍♂️🤦🏾‍♂️
4 · Reply
Latest News on AKBA
Akebia Therapeutics, Inc. (AKBA) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 10:21 AM EDT - 4 months ago

Akebia Therapeutics, Inc. (AKBA) Q4 2024 Earnings Call Transcript


Akebia Therapeutics Announces Multiple Positive Business Updates

Jan 13, 2025, 8:00 AM EST - 6 months ago

Akebia Therapeutics Announces Multiple Positive Business Updates


Q3 2024 Earnings: Hold Akebia Therapeutics

Nov 20, 2024, 3:31 PM EST - 8 months ago

Q3 2024 Earnings: Hold Akebia Therapeutics


Akebia Therapeutics to Present at Upcoming Investor Conferences

Aug 26, 2024, 8:00 AM EDT - 11 months ago

Akebia Therapeutics to Present at Upcoming Investor Conferences


U.S. FDA approves Akebia's anemia drug

Mar 27, 2024, 8:45 PM EDT - 1 year ago

U.S. FDA approves Akebia's anemia drug


Magic_Money
Magic_Money Jul. 16 at 10:29 AM
$AKBA Sales cure all concerns. Q2 will highlight SDO uptake. Adoption should be stellar in these early stages. Q3 adds LDO participation. We should see a break of $5 after Q2 ER and head toward $7.5, or more, for Q3 ER.
0 · Reply
King_JK
King_JK Jul. 16 at 10:00 AM
$AKBA 7.5$
0 · Reply
Nikkosi
Nikkosi Jul. 16 at 9:42 AM
$AKBA I’m expecting a PR around July 30th with the earnings report date. Until then, don’t count on any other announcements. Shorts will likely try to drag this down to key support levels in the meantime. This might be a good time to grab some before the earnings run-up.
0 · Reply
BioLove
BioLove Jul. 16 at 7:38 AM
0 · Reply
Bulltrader988
Bulltrader988 Jul. 16 at 5:58 AM
$AKBA waiting for news and earnings 🦄👃👀
0 · Reply
Djinn88
Djinn88 Jul. 16 at 5:53 AM
$AKBA Blocked Pithy. Jesus does this guy have a life? Literally posting every 5 minutes.
1 · Reply
Mr_Pithy
Mr_Pithy Jul. 16 at 5:22 AM
$AKBA AKEBIA EARNINGS “BLOWOUT” OR “BEAT” IN 2ND QUARTER 2025 - Earnings “blowout” occurs when a company significantly beats earnings expectations. Analysts publish their earnings expectations before earnings are announced. Earnings expectations from all of the analysts who are following a company, are added together and averaged out, creating a consensus earnings estimate. If the earnings number is much higher (~$100M) than the consensus estimate, then this constitutes an earnings blowout. A blowout is not the same as when a company “beats” analysts expectations, as Akebia did in the 1st quarter of 2025. Revenues exceeded analysts estimates by 29%. (Simply Wall St., May 10, 2025). Expect an earnings blowout on August 7, 2025 (unconfirmed), Akebia’s business and financial highlights conference call. (See @Mr_Pithy 07-15-25 at 7:08 p.m.) Good luck 🍀 to all of us.
1 · Reply
StockHawkZero
StockHawkZero Jul. 16 at 5:17 AM
$AKBA I love how the short borrow rates have doubled in the past couple of months. It must be so painful not to be able to cover. Poor shorties. Said figuratively and soon - very much realistically.
0 · Reply
PharmaExpert
PharmaExpert Jul. 16 at 3:08 AM
$AKBA Blowout (minimum 100m) Q2 Earning report coming in 4 weeks! 🔥 https://www.nasdaq.com/market-activity/stocks/akba/earnings
0 · Reply
Lorenzo89
Lorenzo89 Jul. 15 at 11:18 PM
$AKBA folks why this thang ain’t moving ??!🤦🏾‍♂️🤦🏾‍♂️
4 · Reply
Mr_Pithy
Mr_Pithy Jul. 15 at 10:59 PM
$AKBA OUR CAPITAL STRUCTURE, MARKET CAPITALIZATION AND ENTERPRISE VALUE ARE STARTING TO LOOK VERY STRONG. GOOD LUCK 🍀 TO ALL OF US.
1 · Reply
jacksparo
jacksparo Jul. 15 at 10:53 PM
$SLS $ALT $GNS $BTBT $AKBA Important week here . Let’s us see what we will have till Friday ✅⚡️✅ https://t.me/+ar4KYt0qiqs5M2Yx
2 · Reply
Mr_Pithy
Mr_Pithy Jul. 15 at 10:51 PM
$AKBA AKBA 3 MONTH +116.94%, SP500 +15.96%. AKBA 6 MONTH +110.05%, SP500 +7.28%, AKBA 9 MONTH 200.76%, SP500 6.90%, AKBA 1 YEAR 215.08%, SP500 11.63%. AKBA OR SP500? NO BRAINER. GOOD LUCK 🍀
0 · Reply
FinJay
FinJay Jul. 15 at 9:24 PM
$AKBA https://youtu.be/NGUafqO670M
1 · Reply
Nikkosi
Nikkosi Jul. 15 at 9:22 PM
$AKBA should be called SilentBear69 .. be weary of wolf in sheep clothing…
2 · Reply
Mr_Pithy
Mr_Pithy Jul. 15 at 9:18 PM
$AKBA DO WE EXPECT RETURNS ON OUR AKBA INVESTMENT? YOU DECIDE - 109% (3 MONTHS), 887% (3 YEARS). GOOD LUCK 🍀
1 · Reply
Mr_Pithy
Mr_Pithy Jul. 15 at 9:07 PM
$AKBA FINTEL REPORTED THAT ON JULY 15, 2024, AKBA’S SHARE PRICE WAS $1.31 AND THAT ON JULY 14, 2025, SHARE PRICE WAS $3.97. THIS WAS A 203.05% INCREASE OVER THAT PERIOD OF TIME. WE’VE SEEN NOTHING YET.
1 · Reply
MGeronimo
MGeronimo Jul. 15 at 8:53 PM
$AKBA 2 kidney drugs already being sold …MIGHT BE A SATUTN ROCKET STOCK……
1 · Reply
Mr_Pithy
Mr_Pithy Jul. 15 at 8:44 PM
$AKBA TREND IS OUR FRIEND. 99.04% (2023), 49.61% (2024), 108.95% (2025). NOTE THAT LAST 3 YEARS ARE THE BEST IN HISTORY. EXPECT RECORD BREAKING ANNUAL STOCK PRICE PERFORMANCE IN 2026. GOOD LUCK 🍀 TO US
0 · Reply
MGeronimo
MGeronimo Jul. 15 at 8:38 PM
$AKBA NEW 52 week high coming soon
2 · Reply
PharmaExpert
PharmaExpert Jul. 15 at 8:37 PM
$AKBA is it wednesday yet! 🔥
1 · Reply
MGeronimo
MGeronimo Jul. 15 at 8:37 PM
$AKBA IN AT 3.88 2x normal buy in
0 · Reply